摘要
医疗机构中药制剂是中医药特色的体现,也是中药新药创制的重要的源泉。该文通过对全国31个省份的医疗机构中药制剂开展调研,系统梳理其现状、存在问题及发展趋势,结合中药注册和管理的法规要求,提出了基于医疗机构中药制剂向中药新药转化的发展路径,为促进中医药的传承创新发展提供新的思路。
Traditional Chinese medicine(TCM)preparations in medical institutions embody the characteristics of TCM and are the source for the development of new TCM drugs.This study summarizes the current situation,existing problems,and development trends of the TCM preparations in medical institutions in 31 provinces across China.Furthermore,this paper puts forward the development path of new TCM preparations based on the requirements of registration and management regulations of TCM preparations,providing new ideas for promoting the inheritance,innovation,and development of TCM.
作者
马忠明
欧阳辉
倪健
吕泽
李瀚
MA Zhong-ming;OUYANG Hui;NI Jian;LYU Ze;LI Han(Science and Technology Department,National Administration of Traditional Chinese Medicine,Beijing 100027,China;Jiangxi University of Chinese Medicine,Nanchang 330004,China;Beijing University of Chinese Medicine,Beijing 100105,China;the Third Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310005,China)
出处
《中国中药杂志》
CAS
CSCD
北大核心
2024年第5期1415-1420,共6页
China Journal of Chinese Materia Medica
基金
江西中医药大学校级科技创新团队发展计划项目(CXTD22001)
2022年国家青年岐黄学者项目。
关键词
医疗机构院内制剂
发展路径
传承创新
traditional Chinese medicine preparations in medical institutions
development path
inheritance and innovation
